Insurers have their work cut out for them as they come up with plans for riders to cover treatments and drugs that are not on the Cancer Drug List (CDL). They are expected to announce their proposals towards the end of the year - before the treatment regime changes in April next year.
It will be tricky to provide coverage to those who want options beyond the CDL, while keeping premiums reasonable.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
